Cargando…

Validation of the cobas 6800 human papillomavirus test in primary cervical screening

Evaluation of Human Papillomavirus (HPV) testing systems suitable for large-scale organized cervical screening programs is required. We evaluated the cobas 6800 HPV test system for detection of cervical intraepithelial neoplasia grade 3 or worse (CIN3+) when nested in an organized primary HPV screen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sundström, Karin, Lamin, Helena, Dillner, Joakim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894810/ https://www.ncbi.nlm.nih.gov/pubmed/33606755 http://dx.doi.org/10.1371/journal.pone.0247291

Ejemplares similares

Clinical Validation of the cobas HPV Test on the cobas 6800 System for the Purpose of Cervical Screening
por: Saville, Marion, et al.
Publicado: (2019)

Organized primary human papillomavirus–based cervical screening: A randomized healthcare policy trial
por: Elfström, K. Miriam, et al.
Publicado: (2021)

Clinical Performance of Cobas 6800 for the Detection of High-Risk Human Papillomavirus in Urine Samples
por: Hajjar, Brian Joseph, et al.
Publicado: (2023)

HPV testing for cervical cancer screening: technical improvement of laboratory logistics and good clinical performance of the cobas 6800 in comparison to the 4800 system
por: Frayle, Helena, et al.
Publicado: (2019)

Nationwide comprehensive human papillomavirus (HPV) genotyping of invasive cervical cancer
por: Lagheden, Camilla, et al.
Publicado: (2018)

Trichomonas vaginalis Detection in Female Specimens with cobas(®) TV/MG for use on the cobas(®) 6800/8800 Systems
por: Marlowe, Elizabeth M., et al.
Publicado: (2019)

Impact of cervical screening by human papillomavirus genotype: Population-based estimations
por: Wang, Jiangrong, et al.
Publicado: (2023)

Quality assurance in human papillomavirus testing for primary cervical screening
por: Cuschieri, Kate, et al.
Publicado: (2023)

Evaluating the Efficiency of the Cobas 6800 System for BK Virus Detection in Plasma and Urine Samples
por: Song, Junhyup, et al.
Publicado: (2023)

Evaluation of the Performance of the Cobas CT/NG Test for Use on the Cobas 6800/8800 Systems for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Male and Female Urogenital Samples
por: Van Der Pol, Barbara, et al.
Publicado: (2019)

Randomised healthcare policy evaluation of organised primary human papillomavirus screening of women aged 56–60
por: Lamin, Helena, et al.
Publicado: (2017)

Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening
por: Ejegod, Ditte Møller, et al.
Publicado: (2020)

Multisite Performance Evaluation of the cobas 5800 System and Comparison to the cobas 6800/8800 Systems for Quantitative Measurement of HBV, HCV, and HIV-1 Viral Load
por: Tschäpe, Jakob, et al.
Publicado: (2022)

Comparison of the Roche cobas 6800 SARS-CoV-2 test and the Taiwan CDC protocol for the molecular diagnosis of COVID-19
por: You, Huey-Ling, et al.
Publicado: (2021)

Clinical establishment of a laboratory developed quantitative HDV PCR assay on the cobas6800 high-throughput system
por: Pflüger, Lisa Sophie, et al.
Publicado: (2021)

Reply to “Comparison of the Roche cobas 6800 SARS-CoV-2 test and the Taiwan CDC protocol for the molecular diagnosis of COVID-19”
por: You, Huey-Ling, et al.
Publicado: (2021)

Deep sequencing detects human papillomavirus (HPV) in cervical cancers negative for HPV by PCR
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2020)

Comparative effectiveness study on human papillomavirus detection methods used in the cervical cancer screening programme
por: Nygård, Mari, et al.
Publicado: (2014)

Evaluation of sample pooling for SARS-CoV-2 RNA detection in nasopharyngeal swabs and salivas on the Roche Cobas 6800
por: McMillen, Tracy, et al.
Publicado: (2021)

Multicenter comparison of the Cobas 6800 system with the RealStar RT-PCR kit for the detection of SARS-CoV-2
por: Wirden, Marc, et al.
Publicado: (2020)

Performance Evaluation of the Aptima Assays in Comparison with the cobas 6800 Assays for the Detection of HIV-1, HBV, and HCV in Clinical Samples
por: Park, Younhee, et al.
Publicado: (2022)

Human papillomavirus type 16 genomic variation in women with subsequent in situ or invasive cervical cancer: prospective population-based study
por: Arroyo-Mühr, Laila Sara, et al.
Publicado: (2018)

Test Agreement between Roche Cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 Assays at High Cycle Threshold Ranges
por: Broder, Kari, et al.
Publicado: (2020)

Consistency evaluation of Liferiver, Yaneng, Darui, and the Cobas 4800 test for high‐risk human papillomavirus screening
por: Wang, Mengmeng, et al.
Publicado: (2020)

High-risk human papillomavirus status and prognosis in invasive cervical cancer: A nationwide cohort study
por: Lei, Jiayao, et al.
Publicado: (2018)

Human papillomavirus self‐sampling with mRNA testing benefits routine screening
por: Auvinen, Eeva, et al.
Publicado: (2022)

Improving human papillomavirus (HPV) testing in the cervical cancer elimination era: The 2021 HPV LabNet international proficiency study
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2022)

Differing Age-Specific Cervical Cancer Incidence Between Different Types of Human Papillomavirus: Implications for Predicting the Impact of Elimination Programs
por: Vänskä, Simopekka, et al.
Publicado: (2020)

Using the 6800 microprocessor
por: Poe, Elmer C
Publicado: (1978)

Prevalence of high-risk human papillomavirus by cobas 4800 HPV test in urban Peru
por: Iwasaki, Ricardo, et al.
Publicado: (2014)

Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model
por: de Kok, Inge M C M, et al.
Publicado: (2012)

Clinical performance of the Roche Cobas 4800 HPV test for primary cervical cancer screening in a Chinese population
por: Liu, Stephanie S., et al.
Publicado: (2022)

High sensitivity and specificity rates of cobas® HPV test as a primary screening test for cervical intraepithelial lesions in a real-world setting
por: Fleider, Laura Alicia, et al.
Publicado: (2023)

The performance of Cobas HPV test for cervical cancer screening in Chinese female migrant workers
por: He, Yaojuan, et al.
Publicado: (2021)

Prevalence of human papillomavirus infection among Iranian women using COBAS HPV DNA testing
por: Jamdar, Farzane, et al.
Publicado: (2018)

Primary cervical screening with high risk human papillomavirus testing: observational study
por: Rebolj, Matejka, et al.
Publicado: (2019)

Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden
por: Wang, Jiangrong, et al.
Publicado: (2017)

Stability Study of Cervical Specimens Collected by Swab and Stored Dry Followed by Human Papillomavirus DNA Detection Using the cobas 4800 Test
por: Lin, Chun-Qing, et al.
Publicado: (2017)

The WID-CIN test identifies women with, and at risk of, cervical intraepithelial neoplasia grade 3 and invasive cervical cancer
por: Barrett, James E., et al.
Publicado: (2022)

Human papillomavirus testing as a primary screening tool for cervical cancer
por: Cho, Hyun-Woong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9ah024kr163t38f4ndgel2d75d